RareStone Group

Huangpu, China Founded: 2003 • Age: 23 yrs
Provider of network and treatments to individuals and their families affected by rare diseases drugs
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About RareStone Group

RareStone Group is a company based in Huangpu (China) founded in 2003. RareStone Group operates in a competitive market with competitors including Fagron, Ignota Labs, Revelation Pharma, Syntis and Pharmedium, among others.

  • Headquarter Huangpu, China
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of RareStone Group

Premium access

Detailed funding history for RareStone Group

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by RareStone Group

Investments
Premium access

Investment portfolio details for RareStone Group

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - RareStone Group

Premium access

Detailed financials for RareStone Group

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Rarestone Group Comparisons

RareStone Group Primary company
Description
Provider of network and treatments to individuals and their ...
Location
Huangpu, China
Founded Year
2003
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for RareStone Group

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of RareStone Group

RareStone Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fagron, Ignota Labs, Revelation Pharma, Syntis and Pharmedium, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Drug compounding services are provided by Fagron.
Locked Locked Locked
AI-driven toxicity prediction tools for early-stage drug discovery scientists
Locked Locked Locked
A network of compounding pharmacies is operated nationwide.
Locked Locked Locked
Drug compounding services are provided by Syntis in healthcare.
Locked Locked Locked
Drug compounding services are provided to healthcare facilities nationwide.
Premium access

Detailed competitors of RareStone Group

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Rarestone Group

Premium access

Complete news archive for RareStone Group

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about RareStone Group

RareStone Group was founded in 2003.

RareStone Group is headquartered in Huangpu, China. It is registered at Huangpu, Shanghai, China.

Shawn Xiang is the current CEO of RareStone Group.

RareStone Group was established in 2003 in Huangpu, China, within the healthcare sector focused on rare diseases. Support networks and treatment options are offered to individuals and their families impacted by these conditions. Operations center on facilitating access to specialized care and resources, with services tailored to address the unique challenges of rare disease management in the region.

RareStone Group's top competitors include Syntis, Ignota Labs and Fagron.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available